China Biotech Services Holdings Limited (8037.HK)
HKD 0.4
(0.0%)
HKD 0.4
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 171.63 Million HKD | -73.35% |
| 2022 | 643.97 Million HKD | 167.33% |
| 2021 | 240.88 Million HKD | -38.55% |
| 2020 | 392.01 Million HKD | 279.78% |
| 2019 | 103.22 Million HKD | 447.71% |
| 2018 | 18.84 Million HKD | -63.82% |
| 2017 | 52.09 Million HKD | 9.12% |
| 2016 | 47.73 Million HKD | -64.71% |
| 2015 | 135.28 Million HKD | 4.78% |
| 2014 | 129.1 Million HKD | -11.69% |
| 2013 | 146.18 Million HKD | 73.81% |
| 2012 | 84.11 Million HKD | -14.26% |
| 2011 | 98.1 Million HKD | -2.68% |
| 2010 | 100.8 Million HKD | -4.81% |
| 2009 | 105.89 Million HKD | -6.94% |
| 2008 | 113.78 Million HKD | 15.7% |
| 2007 | 98.35 Million HKD | 9.49% |
| 2006 | 89.83 Million HKD | 76.25% |
| 2005 | 50.96 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 249.22 Million HKD | 45.21% |
| 2024 Q2 | 249.22 Million HKD | 0.0% |
| 2023 Q3 | - HKD | -100.0% |
| 2023 Q1 | - HKD | -100.0% |
| 2023 FY | 171.63 Million HKD | -73.35% |
| 2023 Q2 | 247.22 Million HKD | 0.0% |
| 2023 Q4 | 171.63 Million HKD | 0.0% |
| 2022 Q1 | - HKD | -100.0% |
| 2022 FY | 643.97 Million HKD | 167.33% |
| 2022 Q4 | 643.97 Million HKD | 0.0% |
| 2022 Q2 | 352.49 Million HKD | 0.0% |
| 2021 Q4 | 240.88 Million HKD | 0.0% |
| 2021 FY | 240.88 Million HKD | -38.55% |
| 2021 Q1 | - HKD | -100.0% |
| 2021 Q2 | 348.49 Million HKD | 0.0% |
| 2020 Q4 | 392.01 Million HKD | 0.0% |
| 2020 Q2 | 161.8 Million HKD | 0.0% |
| 2020 Q1 | - HKD | -100.0% |
| 2020 FY | 392.01 Million HKD | 279.78% |
| 2019 Q4 | 103.22 Million HKD | 0.0% |
| 2019 Q2 | 87.06 Million HKD | 0.0% |
| 2019 FY | 103.22 Million HKD | 447.71% |
| 2019 Q1 | - HKD | -100.0% |
| 2018 Q4 | 18.84 Million HKD | 0.0% |
| 2018 Q1 | - HKD | -100.0% |
| 2018 Q2 | 52.93 Million HKD | 0.0% |
| 2018 FY | 18.84 Million HKD | -63.82% |
| 2017 FY | 52.09 Million HKD | 9.12% |
| 2017 Q4 | 52.09 Million HKD | 0.0% |
| 2017 Q2 | 46.81 Million HKD | 0.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2016 Q2 | 44.18 Million HKD | 0.0% |
| 2016 Q1 | - HKD | -100.0% |
| 2016 FY | 47.73 Million HKD | -64.71% |
| 2016 Q4 | 47.73 Million HKD | 0.0% |
| 2015 Q4 | 135.28 Million HKD | 0.0% |
| 2015 FY | 135.28 Million HKD | 4.78% |
| 2015 Q2 | 127.45 Million HKD | 0.0% |
| 2015 Q1 | - HKD | -100.0% |
| 2014 Q2 | 139.43 Million HKD | 0.0% |
| 2014 Q1 | - HKD | -100.0% |
| 2014 FY | 129.1 Million HKD | -11.69% |
| 2014 Q4 | 129.1 Million HKD | 0.0% |
| 2013 FY | 146.18 Million HKD | 73.81% |
| 2013 Q4 | 146.18 Million HKD | 0.0% |
| 2013 Q2 | 81.55 Million HKD | 0.0% |
| 2013 Q3 | - HKD | -100.0% |
| 2013 Q1 | 81.55 Million HKD | 0.0% |
| 2012 Q3 | 84.11 Million HKD | 0.0% |
| 2012 Q1 | 108.75 Million HKD | 0.0% |
| 2012 FY | 84.11 Million HKD | -14.26% |
| 2011 Q3 | 98.1 Million HKD | 0.0% |
| 2011 FY | 98.1 Million HKD | -2.68% |
| 2011 Q1 | 104.17 Million HKD | 0.0% |
| 2010 Q1 | 116.78 Million HKD | 0.0% |
| 2010 FY | 100.8 Million HKD | -4.81% |
| 2009 FY | 105.89 Million HKD | -6.94% |
| 2008 FY | 113.78 Million HKD | 15.7% |
| 2007 FY | 98.35 Million HKD | 9.49% |
| 2006 FY | 89.83 Million HKD | 76.25% |
| 2005 FY | 50.96 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Life Healthcare Group Limited | 70.08 Million HKD | -144.897% |